Revance Therapeutics Inc (RVNC) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Revance Therapeutics Inc   (NASDAQ: RVNC)

Revance Therapeutics Inc

Officers & Directors


Mark J. Foley
Chief Executive Officer and Director -


San Jose, California -

Jill Beraud
Director -

Vlad Coric
Director -

Carey O Connor Kolaja
Director -

Chris Nolet
Director -

Olivia C. Ware
Director -

Angus C. Russell
Director, Chairman -

Tobin C. Schilke
Chief Financial Officer -

Mark J. Foley
Chief Executive Officer - (Duly Authorized Principal Executive Officer) By

Julian S. Gangolli
Director -

Tobin C. Schilke
Chief Financial Officer - (Duly Authorized Principal Financial Officer and Principal Accounting Officer),

Revance Therapeutics Inc currently has 534 employees.






RVNC Management Effectiveness RVNC Revenue per Employee RVNC Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.